Rakesh Dhar
Overview
Explore the profile of Rakesh Dhar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goswami J, Cardona J, Hsu D, Simorellis A, Wilson L, Dhar R, et al.
Lancet Infect Dis
. 2024 Nov;
PMID: 39608389
Background: Coadministration of a respiratory syncytial virus (RSV) vaccine with seasonal influenza or SARS-CoV-2 vaccines could reduce health-care visits and increase vaccination uptake in older adults who are at high...
2.
Fitz-Patrick D, Mihara H, Mills A, Mithani R, Kapoor A, Dhar R, et al.
Respir Investig
. 2024 Sep;
62(6):1037-1043.
PMID: 39255587
Background: Respiratory syncytial virus (RSV) represents a global health concern, including in older adults. This study assessed the safety and immunogenicity of mRNA-1345, an investigational mRNA RSV vaccine, in adults...
3.
Schnyder Ghamloush S, Essink B, Hu B, Kalidindi S, Morsy L, Egwuenu-Dumbuya C, et al.
Pediatrics
. 2024 May;
153(6).
PMID: 38738290
Objectives: Human metapneumovirus (hMPV) and parainfluenza virus type 3 (PIV3) are common respiratory illnesses in children. The safety and immunogenicity of an investigational mRNA-based vaccine, mRNA-1653, encoding membrane-anchored fusion proteins...
4.
Shaw C, Essink B, Harper C, Mithani R, Kapoor A, Dhar R, et al.
J Infect Dis
. 2024 Feb;
230(3):e647-e656.
PMID: 38385566
Background: An mRNA-based respiratory syncytial virus (RSV) vaccine, mRNA-1345, is under clinical investigation to address RSV disease burden in older adults. Methods: Based on a randomized, observer-blind, placebo-controlled design, this...
5.
Shaw C, Mithani R, Kapoor A, Dhar R, Wilson L, El Asmar L, et al.
J Infect Dis
. 2024 Feb;
230(3):e637-e646.
PMID: 38298125
Background: Respiratory syncytial virus (RSV) presents a global health concern. A lipid nanoparticle-encapsulated mRNA-based RSV vaccine (mRNA-1345) that encodes the membrane-anchored RSV prefusion-stabilized F glycoprotein is under clinical investigation. Methods:...
6.
Wilson E, Goswami J, Baqui A, Doreski P, Perez-Marc G, Zaman K, et al.
N Engl J Med
. 2023 Dec;
389(24):2233-2244.
PMID: 38091530
Background: Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F glycoprotein, is under clinical investigation....
7.
Bhalla P, Chadha V, Dhar R, Dhawan D
Indian J Exp Biol
. 2007 Dec;
45(11):954-8.
PMID: 18072539
With a view to find out whether zinc affords protection against lithium toxicity the activities of antioxidant enzymes and lipid peroxidation profile were determined in the cerebrum and cerebellum of...